01 1Alembic Pharmaceuticals Limited
01 1RIVASTIGMINE TARTRATE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-06-06
Pay. Date : 2014-05-30
DMF Number : 21800
Submission : 2008-06-30
Status : Active
Type : II
20
Alembic Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is RIVASTIGMINE TARTRATE USP, with a corresponding US DMF Number 21800.
Remarkably, this DMF maintains an Active status since its submission on June 30, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 06, 2014, and payment made on May 30, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
